160 related articles for article (PubMed ID: 22495167)
41. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
42. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
43. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.
Porapakkham P; Porapakkham P; Zimmet H; Billah B; Krum H
Arch Intern Med; 2010 Mar; 170(6):507-14. PubMed ID: 20308637
[TBL] [Abstract][Full Text] [Related]
44. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
45. Comparative evaluation of B-type natriuretic peptide and mid-regional pro-A-type natriuretic peptide changes from admission to discharge in prognosis of acute decompensated heart failure patients.
Stenner E; Buiatti A; Barbati G; Merlo M; Sinagra G; Biasioli B
Clin Lab; 2012; 58(5-6):585-9. PubMed ID: 22783593
[TBL] [Abstract][Full Text] [Related]
46. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
47. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure.
Maisel A
J Card Fail; 2001 Jun; 7(2):183-93. PubMed ID: 11420771
[TBL] [Abstract][Full Text] [Related]
48. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
49. Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients.
McCullough PA
Minerva Cardioangiol; 2004 Dec; 52(6):479-89. PubMed ID: 15729209
[TBL] [Abstract][Full Text] [Related]
50. [Clinical use of markers of neurohormonal activation in heart failure].
Roig Minguell E
Rev Esp Cardiol; 2004 Apr; 57(4):347-56. PubMed ID: 15104989
[TBL] [Abstract][Full Text] [Related]
51. Natriuretic peptides in the diagnosis and management of acute heart failure.
Mohammed AA; Januzzi JL
Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
[TBL] [Abstract][Full Text] [Related]
52. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
53. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
[TBL] [Abstract][Full Text] [Related]
54. Use of B-type natriuretic peptide outside of the emergency department.
Maeder MT; Mueller C; Pfisterer ME; Buser PT; Brunner-La Rocca HP
Int J Cardiol; 2008 Jun; 127(1):5-16. PubMed ID: 18191484
[TBL] [Abstract][Full Text] [Related]
55. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
[TBL] [Abstract][Full Text] [Related]
56. Novel biomarkers in heart failure: usefulness in clinical practice.
Siasos G; Tousoulis D; Oikonomou E; Kokkou E; Mazaris S; Konsola T; Stefanadis C
Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):311-21. PubMed ID: 24552543
[TBL] [Abstract][Full Text] [Related]
57. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
Motiwala SR; Januzzi JL
Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878
[TBL] [Abstract][Full Text] [Related]
58. Using biomarkers to "guide" heart failure management: current perspectives and future directions.
Motiwala SR; Januzzi JL
Cardiol Rev; 2013; 21(3):127-34. PubMed ID: 23032578
[TBL] [Abstract][Full Text] [Related]
59. Heart failure biomarkers at point-of-care: current utilization and future potential.
Christenson ES; Collinson PO; Defilippi CR; Christenson RH
Expert Rev Mol Diagn; 2014 Mar; 14(2):185-97. PubMed ID: 24524847
[TBL] [Abstract][Full Text] [Related]
60. Carbohydrate antigen 125: a new biomarker in heart failure.
Vizzardi E; D'Aloia A; Curnis A; Dei Cas L
Cardiol Rev; 2013; 21(1):23-6. PubMed ID: 22735832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
